Anthropometric and bone-related biochemical factors are associated with different haplotypes of ANKH locus

Annals of Human Biology

Volumn 35, Issue 5, 2008, Pages 535-546

  Korostishevsky, Michael ^a   Vistoropsky, Yulia ^a   Malkin, Ida ^a   Kobyliansky, Eugene ^a   Livshits, Gregory ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ANKH gene; Anthropometric traits; Genetic association; OPG and PTH

Indexed keywords

ANKH PROTEIN, HUMAN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATE TRANSPORTER; PTH PROTEIN, HUMAN;

BIOCHEMISTRY; BONE; GENE; GENETICS; HORMONE;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; BONE; CAUCASIAN; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; HAPLOTYPE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTHROPOMETRY; BODY WEIGHT; BONE AND BONES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 52949129771     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.1080/03014460802304588     Document Type: Article

References (49)

1. Abecasis GR, Cardon LR, Cookson WS. 2002. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66:279-292.
2. Akbari OS, Bousum A, Bae E, Drewell RA. 2006. Unraveling cis-regulatory mechanisms at the abdominal-A and abdominal-B genes in the Drosophila bithorax complex. Dev Biol 293:294-304.
3. An JJ, Han DH, Kim DM, Kim SH, Rhee Y, Lee EJ, Lim SK. 2007. Expression and regulation of osteoprotegerin in adipose tissue. Yonsei Med J 48:765-772.
4. Arko B, Prezelj J, Kocijancic A, Komel R, Marc J. 2005. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas 51:270-279.
5. Bab I, Zimmer A. 2008. Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol 153:182-188.
6. Burkhart TA, Arthurs KL, Andrews DM. 2008. Reliability of upper and lower extremity anthropometric measurements and the effect on tissue mass predictions. J Biomech 41:1604-1610.
7. Cohen Jr MM. 2006. The new bone biology: Pathologic, molecular, and clinical correlates. Am J Med Genet 140:2646-2706.
8. Danilevicius CF, Lopes JB, Pereira RM. 2007. Bone metabolism and vascular calcification. Braz J Med Biol Res 40:435-442.
9. Ermakov S, Malkin I, Keter M, Kobyliansky E, Livshits G. 2008. Family-based association study of polymorphisms in the RUNX2 locus with hand bone length and hand BMD. Ann Hum Genet 72:510-518.
10. Gomez JM, Vilarrasa N, Masdevall C, Pujol J, Solano E, Soler J, Elio I, Gallart L, Vendrell J. 2008. Regulation of bone mineral density in morbidly obese women: A cross-sectional study in two cohorts before and after bypass surgery. Obes Surg (in press).
11. Gurley KA, Reimer RJ, Kingsley DM. 2006. Biochemical and genetic analysis of ANK in arthritis and bone disease. Am J Hum Genet 79:1017-1029.
12. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL. 2004. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: An integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164:1199-1209.
13. Ho AM, Johnson MD, Kingsley DM. 2000. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289:265-270.
14. Horvath S, Xu X, Laird NM. 2001. The family based association test method: Strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9:301-306.
15. Hunter D, DeLange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD. 2001. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 16:371-378.
16. Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM. 2007. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause. 14:913-918.
17. Livshits G. 2006. Quantitative genetics of circulating molecules associated with bone metabolism: A review. J. Musculoskelet Neuronal Interact 6:47-61.
18. Livshits G, Karasik D, Kobyliansky E. 2002. Complex segregation analysis of the radiographic phalanges bone mineral density and their age-related changes. J Bone Miner Res 17:152-161.
19. Livshits G, Pantsulaia I, Trofimov S, Kobyliansky E. 2004. Genetic influences on the circulating cytokines involved in osteoclastogenesis. J Med Genet. 41:e76.
20. Lohman TG, Roche AF, Martorell R. 1988. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics.
21. Malkin I, Ginsburg E. 2007. Program package for pedigree analysis (version MAN-7). Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University; Technical Report.
22. Malkin I, Dahm S, Suk A, Kobyliansky E, Toliat M, Ruf N, Livshits G, Nurnberg P. 2005. Association of ANKH gene polymorphisms with radiographic hand bone size and geometry in a Chuvasha population. Bone 36:365-373.
23. Malkin I, Ermakov S, Kobyliansky E, Livshits G. 2006. Strong association between polymorphisms in ANKH locus and skeletal size traits. Hum Genet 120:42-51.
24. Malkin I, Ginsburg E, Elston RC. 2002b. Increase in power of transmission-disequilibrium tests for quantitative traits. Genet Epidemiol 23:234-244.
25. Malkin I, Karasik D, Livshits G, Kobyliansky E. 2002a. Modelling of age-related bone loss using cross-sectional data. Ann Hum Biol 29:256-70.
26. Moffett SP, Oakley JI, Cauley JA, Lui LY, Ensrud KE, Taylor BC, Hillier TA, Hochberg MC, Li J, Cayabyab S, et al. 2008. Study of osteoporotic fractures research group. Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women. J Clin Endocrinol Metab 93:2002-2008.
27. Moochhala SH, Sayer JA, Carr G, Simmons NL. 2008. Renal calcium stones: Insights from the control of bone mineralisation. Exp Physiol 93:43-49.
28. Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, Leschik G, Uhlmann K, Mischung C, Harrop K, et al. 2001. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet 28:37-41.
29. Ozdemir FN, Sezer S, Atac B, Tutal E, Verdi H, Sahin F, Haberal M. 2005. Vitamin D receptor BsmI and TagI gene polymorphisms in a Turkish ESRD population: Influences on parathyroid hormone response. Transplant Proc 37:2922-2924.
30. Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, Zannettino AC. 2004. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res 19:147-154.
31. Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, Dixey J, Gillet P, Loeuille D, McGrath R, et al. 2004. Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet 71:933-940.
32. Pulsatelli L, Dolzani P, Silvestri T, Caraceni P, Facchini A, Ravaglia G, Salvarani C, Melicòni R, Mariani E. 2004. Soluble receptor activator of nuclear factor- kappaB Ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases. Biogerontology 5:119-127.
33. Qin L, Raggatt LJ, Partridge NC. 2004. Parathyroid hormone: A double-edged sword for bone metabolism. Trends Endocrinol Metab 15:60-65.
34. Reichenberger E, Tiziani V, Watanabe S, Park L, Ueki Y, Santanna C, Baur ST, Shiang R, Grange DK, Beighton P, et al. 2001. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Gene 68:1321-1326.
35. Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W. 2007. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol. 157:225-232.
36. Rhee EJ, Oh KW, Yun EJ, Jung CH, Park CY, Lee WY, Oh ES, Baek KH, Kang MI, Park SW, et al. 2007. The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women. Exp Mol Med. 39:696-704.
37. Rice T, Després JP, Daw EW, Gagnon J, Borecki IB, Pérussae L, Leon AS, Skinner JS, Wilmore JH, Rao DC, et al. 1997. Familial resemblance for abdominal visceral fat: The HERITAGE family study. Int J Obes Relat Metab Disord 21:1024-1031.
38. Rodan GA. 2002. Bisphosphonates and primary hyperparathyroidism. J Bone Miner Res 17:150-153.
39. Tang ZH, Xiao P, Lei SF, Deng FY, Zhao LJ, Deng HY, Tan LJ, Shen H, Xiong DH, Recker RR, et al. 2007. A bivariate whole-genome linkage scan suggests several shared genomic regions for obesity and osteoporosis. J Clin Endocrinol Metab 92:2751-2757.
40. Tenne M, McGuigan F, Jansson L, Gerdhem P, Obrant KJ, Luthman H, Akesson K. 2008. Genetic variation in the PTH pathway and bone phenotypes in elderly women: Evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone 42:719-727.
41. Trofimov S, Pantsulaia I, Kobyliansky E, Livshits G. 2004. Circulating levels of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin/ macrophage-colony stimulating factor in a presumably healthy human population. Eur J Endocrinol 150:305-11.
42. Tsui HW, Inman RD, Paterson AD, Reveille JD, Tsui FW. 2005. ANKH variants associated with ankylosing spondylitis: Gender differences. Arthritis Res Ther 7:R513-25.
43. Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH, Devine A, Prince RL. 2007. No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone 40:175-181.
44. Van Beek ER, Lowik CW, Papapoulos SE. 2002. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: The role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors. Bone 30:64-70.
45. Vistoropsky Y, Keter M, Malkin I, Trofimov S, Kobyliansky E, Livshits G. 2007a. Contribution of the putative genetic factors and ANKH gene polymorphisms to variation of circulating calciotropic molecules, PTH and BGP. Hum Mol Genet 16:1233-1240.
46. Vistoropsky Y, Malkin I, Kobyliansky E, Livshits G. 2007b. Osteoprotegerin plasma levels are strongly associated with polymorphisms in human homologue of the mouse progressive ankylosis (ANKH) gene. Ann Hum Genet 71:302-307.
47. Williams FM, Spector TD. 2007. The genetics of osteoporosis. Acta Reumatol Port 32:231-240.
48. Williams FM, Spector TD. 2006. Recent advances in the genetics of osteoporosis. J Musculoskelet Neuronal Interact 6:27-35.
49. Zaka R, Williams CJ. 2006. Role of the progressive ankylosis gene in cartilage mineralization. Curr Opin Rheumatol 18:81-186.